These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Plasma endothelin-1 concentrations in children with cirrhosis and their relationship to renal function and the severity of portal hypertension. Bakr AM; Abdalla AF; El-Marsafawy H; Abu-Hashem I; El-Regal ME; Amer T; Abdel-Khalik MK; Mostafa H; A-Kader HH J Pediatr Gastroenterol Nutr; 2002 Aug; 35(2):149-53. PubMed ID: 12187289 [TBL] [Abstract][Full Text] [Related]
23. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis. Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437 [TBL] [Abstract][Full Text] [Related]
25. Hemodynamic and renal effects of ascites apheresis, concentration and reinfusion in advanced cirrhosis. Bernardi M; Gasbarrini A; Trevisani F; Caraceni P; De Collibus C; Colantoni A; Andreone P; Cursaro C; Ligabue A; Gasbarrini G J Hepatol; 1995 Jan; 22(1):10-6. PubMed ID: 7751575 [TBL] [Abstract][Full Text] [Related]
26. Effects of somatostatin on renal function in cirrhosis. Ginès A; Salmerón JM; Ginès P; Jiménez W; Saló J; Piera C; Clària J; Rivera F; Arroyo V; Rodés J Gastroenterology; 1992 Dec; 103(6):1868-74. PubMed ID: 1360435 [TBL] [Abstract][Full Text] [Related]
27. Acute effects of captopril on systemic and renal hemodynamics and on renal function in cirrhotic patients with ascites. Pariente EA; Bataille C; Bercoff E; Lebrec D Gastroenterology; 1985 May; 88(5 Pt 1):1255-9. PubMed ID: 3884428 [TBL] [Abstract][Full Text] [Related]
28. Adrenomedullin contributes to vascular hyporeactivity in cirrhotic rats with ascites via a release of nitric oxide. Kojima H; Sakurai S; Uemura M; Satoh H; Nakashima T; Minamino N; Kangawa K; Matsuo H; Fukui H Scand J Gastroenterol; 2004 Jul; 39(7):686-93. PubMed ID: 15370692 [TBL] [Abstract][Full Text] [Related]
29. Effects of captopril on renal functions, renal and portal hemodynamics in patients with cirrhosis. Tsai YT; Lin HC; Lee FY; Hou MC; Wang SS; Lee SD Proc Natl Sci Counc Repub China B; 1996 Apr; 20(2):44-50. PubMed ID: 8931343 [TBL] [Abstract][Full Text] [Related]
31. Internal dysregulation of the renin system in patients with stable liver cirrhosis. Fialla AD; Thiesson HC; Bie P; Schaffalitzky de Muckadell OB; Krag A Scand J Clin Lab Invest; 2017 Jul; 77(4):298-309. PubMed ID: 28417649 [TBL] [Abstract][Full Text] [Related]
32. Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. Laffi G; Pinzani M; Meacci E; La Villa G; Renzi D; Baldi E; Cominelli F; Marra F; Gentilini P Gastroenterology; 1989 Jan; 96(1):167-77. PubMed ID: 2535828 [TBL] [Abstract][Full Text] [Related]
33. Renal hemodynamics in patients with cirrhosis: relationship with ascites and liver failure. Moreau R; Gaudin C; Hadengue A; Braillon A; Roulot D; Bacq Y; Lebrec D Nephron; 1993; 65(3):359-63. PubMed ID: 8289984 [TBL] [Abstract][Full Text] [Related]
34. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment. Wong F; Raina N; Richardson R Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033 [TBL] [Abstract][Full Text] [Related]
35. Diagnosis of functional kidney failure of cirrhosis with Doppler sonography: prognostic value of resistive index. Maroto A; Ginès A; Saló J; Clària J; Ginès P; Anibarro L; Jiménez W; Arroyo V; Rodés J Hepatology; 1994 Oct; 20(4 Pt 1):839-44. PubMed ID: 7927224 [TBL] [Abstract][Full Text] [Related]
36. Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation. Bernardi M; Trevisani F; Santini C; De Palma R; Gasbarrini G Gut; 1983 Aug; 24(8):761-6. PubMed ID: 6347831 [TBL] [Abstract][Full Text] [Related]
37. LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction. Nazar A; Guevara M; Sitges M; Terra C; Solà E; Guigou C; Arroyo V; Ginès P J Hepatol; 2013 Jan; 58(1):51-7. PubMed ID: 22989573 [TBL] [Abstract][Full Text] [Related]
38. Long-term administration of isosorbide-5-mononitrate does not impair renal function in cirrhotic patients. Salerno F; Borroni G; Lorenzano E; Solenghi D; Cazzaniga M; Bissoli F; Ceriani R; deFranchis R Hepatology; 1996 May; 23(5):1135-40. PubMed ID: 8621145 [TBL] [Abstract][Full Text] [Related]
39. Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites. Sàbat M; Guarner C; Soriano G; Bulbena O; Novella MT; Ortiz J; Ricart E; Villanueva C; Rosello J; Rodríguez J; Balanzó J Dig Dis Sci; 1998 Oct; 43(10):2184-9. PubMed ID: 9790452 [TBL] [Abstract][Full Text] [Related]
40. Dendroaspis natriuretic peptide in hepatic cirrhosis. Fábrega E; Crespo J; Rivero M; Casafont F; Castro B; García-Unzueta MT; Amado JA; Pons-Romero F Am J Gastroenterol; 2001 Sep; 96(9):2724-9. PubMed ID: 11569702 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]